Use of Lung Ultrasound in Children With Acute Bronchiolitis
Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Sep 10, 2017
Trial Information
Current as of September 30, 2025
Completed
Keywords
ClinConnect Summary
Bronchiolitis is the most common lower respiratory tract infection that affects children younger than 24 months. The diagnosis is clinical and, according to international guidelines, chest x-ray (CXR) should be reserved for cases in which signs of pulmonary complications are present or where respiratory effort is severe to warrant intensive care unit admission. Despite these recommendations, CXR is still performed in about 50% of bronchiolitis (ranging from 24 to 77%), which exposes infants to ionizing radiation.
Given its portability, no ionizing radiation, rapid and repeat testing, lung ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children hospitalized with a diagnosis of bronchiolitis
- • Age \< 24 months
- • CXR as part of usual clinical practice because of clinical suspicion of pulmonary complications
- • Informed written consent
- Exclusion Criteria:
- • chronic respiratory disease (i.e. bronchopulmonary dysplasia)
- • congenital heart disease
- • severe neuromuscular disease
- • congenital or acquired immunodeficiency
About Irccs Azienda Ospedaliero Universitaria Di Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, Bo, Italy
Patients applied
Trial Officials
Marcello Lanari, Professor
Principal Investigator
Pediatric Emergency Unit, S. Orsola-Malpighi Hospital, University of Bologna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials